Review of the clinical effectiveness and cost effectiveness of paclitaxel for ovarian cancer.

Commissioned to inform NICE Technology Appraisal 55:

Research output: Book/ReportCommissioned report

Original languageEnglish
Place of PublicationLondon:
PublisherNational Institute for Health and Clinical Excellence
Publication statusPublished - 2003

Publication series

NameNICE Technology Appraisal Guidance; no 55

Cite this